HRSA issued a Federal Tort Claims Act (FTCA) particularized determination permitting health centers to prescribe and dispense naloxone to individuals who are not patients of the health center. The determination allows health centers that have been deemed as Public Health Service employees for purposes of liability protections and any officer, governing board member, employee, qualified contractor, or VHP of such an entity (“eligible individuals”), to have liability protections under section 224 of the Public Health Service Act for the provision of health services within the health center’s scope of the project to individuals who are not patients of the health center for prescribing and dispensing naloxone at a health center service site or at offsite locations within the community served by the health center and where the health center is providing care.
